Health Care Professionals

As a health care professional in New Hampshire, you can play a key role in reducing the spread of tickborne diseases.

New Hampshire has been impacted significantly by tickborne diseases. Approximately 1,170 people in New Hampshire are newly diagnosed with Lyme disease annually. Yet according to our statewide survey responses, about 40% of residents believe they are at a low or no risk of contracting Lyme disease.

Order or download and print our patient conversation guide, along with other educational resources in our Online Shop and our Partner Toolkit.

Subscribe to Tick Free NH to receive quarterly updates on Health Care Practice Resources, timely tick information, and new product releases.

Receive quarterly updates on Health Care Practice Resources, timely tick information, and new product releases.

Get Involved

If you are an active or retired healthcare worker, or are a student or trainee in any healthcare-related discipline in New Hampshire, please support NH Healthy Climate, a young grassroots and nonpartisan organization! Healthcare workers are uniquely positioned to increase public awareness of the links between health and climate change. NH Healthy Climate seeks to provide NH healthcare workers the tools to educate and mobilize the public in support of climate solutions to improve health for all, including reducing exposure to vector-borne diseases.

health care professional is examining a specimen with her microscope

Join the Tick Free NH Council

The Tick Free NH Council is an advisory group that convenes quarterly to prioritize prevention activities and identify and leverage partnerships in tickborne disease prevention. Tick Free NH is a donor-funded project which provides education and resources at no-cost to all New Hampshire residents to help them protect themselves from tick encounters. Contact us for more information about the council and Subscribe to Tick Free NH to keep in touch and up-to-date.

Further Provider Resources

early career doctor is listening to her patient in the medical exam room
In 2022, the CDC’s Tick-Borne Disease Working Group released their third and final Report to Congress. At a high level, they identified four areas of priority:

Commitment of national-level resources
Commit national-level resources in the areas of: disease and tick surveillance, biorepositories for specimens, and national databases, would accelerate recognition of new threats, development of new diagnostics and treatments, and identification of the pathogenesis of disease.

Development of a tickborne disease portfolio
Develop a tickborne disease portfolio in the Advanced Research Project Agency for Health (ARPA-H) and Biomedical Advanced Research and Development Authority (BARDA). This would likely improve coordination across agencies and accelerate progress toward improving patient care and address deficiencies identified in the tickborne disease diagnostics and therapeutics discovery pipelines.

Prioritization of health care access for sufferers of tickborne diseases and associated illnesses.
Recent advances in the care of at-risk patients include improved access to telemedicine in areas where health care providers lack expertise in tick-borne diseases and associated illnesses; better understanding of the clinical presentation of tick-borne diseases, particularly in populations that are commonly under-evaluated such as prisoners, individuals in psychiatric facilities, and migrant workers; establishment of safety standards for individuals in high-risk occupations; and labeling of food, medical, and commercial products to protect patients with Alpha-gal Syndrome.

Creation of targeted funding opportunities
Create targeted funding opportunities in understudied areas, including: development of tick control and preventive agents against tick bites; improved diagnostics for multiple diseases; vaccines; treatments for tickborne viruses and persistent symptoms of Lyme disease; and additional studies of central nervous system and psychiatric manifestations of tickborne illnesses, effects on pregnancy, and development of post-tick bite allergies to alpha galactosidase.